Molecular Mechanisms of Breast Cancer Treatments-Related Side Effects and Precision Interventions
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 26 May 2026 | Viewed by 1
Special Issue Editor
Special Issue Information
Dear Colleagues,
More aggressive and effective treatments, particularly in combination, have improved overall survival in breast cancer patients. However, they come at a steep price: debilitating side effects that negatively impact patients’ quality of life. Many patients endure a grueling, acute, and prolonged battle against fatigue, cognitive impairment, chronic pain, and overall ill health. To improve the clinical outcomes of breast cancer, we need to preserve the quality of life of cancer survivors in addition to developing new treatments. This requires a radical shift from one-size-fits-all approaches to a new era of precision medicine and interventions. By pinpointing the specific molecular mechanisms of side effects, we can develop highly targeted precision interventions. The future of cancer care will tailor more effective treatments to the individual using pharmacogenomics and biomarker-guided therapies and interventions. The goal is to optimize treatments, minimize side effects, and improve clinical outcomes for breast cancer survivors.
Prof. Dr. Jennifer Hu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- treatment-related side effects
- biomarker
- precision interventions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
